Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus–associated Posttransplant Lymphoproliferativ... by Victor H. Ferreira, PhD, Rafaela V. P. Ribeiro, MD, PhD, Faranak Mavandadnejad, PhD, Matthew Ierullo, MSc, Beata Majchrzak-Kita, MSc, Aizhou Wang, PhD, Lianne Singer, MD, Shaf Keshavjee, MD, Marcelo Cypel, MD, PhD, Deepali Kumar, MD, Atul Humar, MD

Get full text